Live Breaking News & Updates on Michel Lussier

Stay updated with breaking news from Michel lussier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United Kingdom , Mont Saint Guibert , Waals Gewest , Michel Lussier , Stefan Klotter , David Georges , Company Or Celyad Oncology , Exchange Commission , Regulatory News , Belgian Law , Double Voting Right , Chief Executive Officer , Celyad Oncology , Private Securities Litigation Reform Act , Annual Report , Lassen Sie ,

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Mont Saint Guibert , Waals Gewest , Michel Lussier , Company Or Celyad Oncology , Exchange Commission , Belgian Law , Double Voting Right , Chief Executive Officer , Celyad Oncology , Private Securities Litigation Reform Act , Annual Report ,

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Mont Saint Guibert , Waals Gewest , Michel Lussier , David Georges , Company Or Celyad Oncology , Exchange Commission , Total Number , Voting Rights , Belgian Law , Double Voting Right , Chief Executive Officer , Celyad Oncology , Private Securities Litigation Reform Act , Annual Report , Media Contact ,

Celyad announces management change

Celyad announces management change
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Mont Saint Guibert , Waals Gewest , Hilde Windels , Georges Rawadi , David Georges , Michel Lussier , Exchange Commission , Friday December , Celyad Oncology , Private Securities Litigation Reform Act , Annual Report , Oncology Investor , Media Contact ,

Celyad Announces Management Change

MONT-SAINT-GUIBERT, Belgium, December 04, 2023 Regulatory News: Celyad Oncology (Euronext: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells announces that its CEO and managing director Georges Rawadi has decided to step down, effective as of Friday December 1, 2023. ....

Bruxelles Capitale , Mont Saint Guibert , Waals Gewest , France General , New York , United States , Hilde Windels , Michel Lussier , David Georges , Georges Rawadi , Exchange Commission , Regulatory News , Friday December , Celyad Oncology , Private Securities Litigation Reform Act , Annual Report , Oncology Investor , Media Contact , The Company , Chimeric Antigen Receptor , Georges Rawadi , Michel Lussier , Forward Looking Statements ,